{"id":"NCT00726388","sponsor":"Pfizer","briefTitle":"An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain","officialTitle":"An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09-15","primaryCompletion":"2009-05-08","completion":"2009-05-08","firstPosted":"2008-07-31","resultsPosted":"2021-10-13","lastUpdate":"2021-10-13"},"enrollment":1050,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"DIC075V (intravenous diclofenac sodium)","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"}],"summary":"This is an open-label, multiple-dose, safety study of DIC075V in patients with acute post-operative pain following abdominal or orthopedic surgery.","primaryOutcome":{"measure":"Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)","timeFrame":"Day 1 of dosing up to maximum of 37 days after last dose (maximum up to 42 days)","effectByArm":[{"arm":"DIC075V","deltaMin":823,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":46,"countries":["United States"]},"refs":{"pmids":["29492863"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":73,"n":971},"commonTop":["NAUSEA","ANAEMIA POSTOPERATIVE","CONSTIPATION","INSOMNIA","PRURITUS"]}}